Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy

Area of Science:

• Microbiology
• Vaccinology
• Bioinformatics

Background:

• Pneumococcal conjugate vaccines require ongoing surveillance of circulating strains to evaluate efficacy and identify replacement serotypes.
• Traditional serological methods for identifying Streptococcus pneumoniae are inefficient and error-prone.
• Existing DNA-based methods have limited serotype coverage, necessitating multiple polymerase chain reaction (PCR) primers.

Purpose of the Study:

• To develop a novel, cost-effective, and simple sequence-based method for identifying Streptococcus pneumoniae serotypes.
• To design a single PCR primer pair capable of differentiating between pneumococcal serotypes by targeting conserved regions of the capsulation locus (cps).

Main Methods:

• A computer algorithm was employed to analyze the cps of 92 vaccine serotypes, identifying primer pairs within conserved regions flanking variable regions.
• In silico analysis predicted a primer pair spanning the cpsB gene could amplify 84 serotypes and differentiate 46.
• The primer set's specificity was confirmed against other bacterial species, and its performance was evaluated using 138 pneumococcal strains covering 48 serotypes.

Main Results:

• The developed primer set demonstrated specificity for Streptococcus pneumoniae, with no amplification in related species like S. mitis, S. oralis, and S. pseudopneumoniae.
• In silico analysis suggested potential amplification of 84 serotypes and differentiation of 46 using a single primer pair targeting cpsB.
• Experimental testing showed successful identification of 19 out of 22 vaccine serotypes (86%) to at least the serogroup level, including key 13-valent conjugate vaccine and replacement serotypes.

Conclusions:

• A novel, sequence-based method utilizing a single PCR primer pair offers a cost-effective and simple approach for identifying Streptococcus pneumoniae serotypes.
• This method accurately identifies most vaccine serotypes and has the potential to monitor vaccine efficacy and detect emerging or novel serotypes.
• The approach demonstrates reproducibility and specificity, making it a valuable tool for ongoing pneumococcal surveillance.